Citation | Barlind, JG; Bauer, UA; Birch, AM; Birtles, S; Buckett, LK; Butlin, RJ; Davies, RD; Eriksson, JW; Hammond, CD; Hovland, R; Johannesson, P; Johansson, MJ; Kemmitt, PD; Lindmark, BT; Morentin Gutierrez, P; Noeske, TA; Nordin, A; O'Donnell, CJ; Petersson, AU; Redzic, A; Turnbull, AV; Vinblad, J Design and optimization of pyrazinecarboxamide-based inhibitors of diacylglycerol acyltransferase 1 (DGAT1) leading to a clinical candidate dimethylpyrazinecarboxamide phenylcyclohexylacetic acid (AZD7687). J Med Chem55:10610-29 (2012) [PubMed] Article |
---|
SMILES | Cc1nc(C)c(nc1C(N)=O)-c1ccc2c(CC[C@@]22CC[C@@H](CC2)C(O)=O)c1 |r,wD:18.18,21.26,(47.29,-23.74,;48.62,-22.97,;49.97,-23.74,;51.29,-22.97,;52.63,-23.74,;51.29,-21.44,;49.96,-20.66,;48.63,-21.43,;47.29,-20.66,;45.96,-21.43,;47.29,-19.12,;52.62,-20.67,;52.62,-19.12,;53.95,-18.35,;55.29,-19.12,;55.3,-20.66,;56.77,-21.13,;57.67,-19.87,;56.75,-18.63,;55.65,-17.55,;56.05,-16.06,;57.54,-15.65,;58.63,-16.74,;58.23,-18.22,;57.93,-14.17,;59.42,-13.76,;56.84,-13.08,;53.96,-21.44,)| |